Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 627 (ZNF627) is a human protein-coding gene located on chromosome 19. It is predicted to function as a DNA-binding transcription factor, specifically regulating transcription mediated by RNA polymerase II. The protein contains 11 C2H2-type zinc fingers and a Kruppel-associated box (KRAB) domain, characteristic of a large family of transcriptional regulators involved in gene expression modulation. ZNF627 primarily localizes in the nucleus, consistent with its predicted role as a transcriptional regulator. There are currently no well-established biological functions beyond transcriptional regulation, and no recognized disease associations, interacting drugs, or clinical biomarker applications for this protein. The gene is expressed across various human tissues, but its specific physiological roles remain incompletely characterized.
Not applicable. No drugs currently target this protein, and no mechanisms of action have been described or proposed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 627 (ZNF627).